suzuki susumu 鈴木進

… Alternative Names

Suzuki Susumu 鈴木進

SUZUKI Susumu 鈴木進

Less

Researcher Number	70518422
Other IDs
Affiliation (Current)	2024: 愛知医科大学, 研究創出支援センター, 教授
Affiliation (based on the past Project Information) *help	2024: 愛知医科大学, 研究創出支援センター, 教授 2022: 愛知医科大学, 加齢医科学研究所, 准教授 2022: 愛知医科大学, 研究創出支援センター, 准教授 2019 – 2021: 愛知医科大学, 公私立大学の部局等, 准教授 2018: 愛知医科大学, その他部局等, 准教授 2014 – 2017: 愛知医科大学, 医学部, 准教授 2012: 愛知医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor therapeutics Except Principal Investigator Basic Section 56030:Urology-related / Basic Section 56050:Otorhinolaryngology-related / Obstetrics and gynecology / Basic Section 54010:Hematology and medical oncology-related / Otorhinolaryngology / Tumor immunology
Keywords	Principal Investigator CCR4 / 制御性T細胞 / モガムリズマブ / 細胞傷害性T細胞 / がん免疫治療 / CTL / Treg / 疲弊T細胞 / cytotoxic T-cell / immunotherapy … More / regulatory T-cell / RNAscope / TGF-b / CAF / M2マクロファージ / ADCC / MEK / トラメチニブ / TGF-β / バイオマーカー / 多重免疫染色 / フローサイトメトリー / 免疫治療 / 免疫抑制 / がん微小環境 / 免疫療法 / PD-1 / FOXP3 / 頭頸部扁平上皮がん / 免疫抑制環境 / がん複合免疫治療 / 免疫チェックポイント / がん複合免疫療法 / キイトルーダ / オプジーボ / 免疫チェックポイント阻害剤 / ＣＭＶｐｐ65 / FoxP3 / 腫瘍免疫増強 / 免疫不全マウス / CCケモカイン受容体4(CCR4) / エフェクター制御性T細胞 … More Except Principal Investigator 免疫治療 / 頭頸部癌 / 腫瘍免疫学 / 頭頸部外科学 / 進行腎癌一次治療 / バイオマーカー / 制御性Ｔ細胞 / 腎癌 / 免疫 / 頸部郭清術 / 外科腫瘍免疫学 / 子宮頸がん / 細胞膜透過性ペプチド / 組み換え型抗体 / ファージ抗体 / HPV-E7 / ペプチド / 子宮がん / scFv / antibody / HPV18-E7 / HPV16-E7 / cell-penetrating peptide / 膜貫通 / 抗体 / HPV / 遺伝子変異 / alemtuzumab / ヒト急性白血病 / アレンツムマブ / 化合物ライブラリー / アレンツズマブ / CRISPR-Csa9 / ITD / アレムツズマブ / ゲノム編集 / CRISPR-cas9 / 白血病 / CD52 / FLT3 / プロテオーム / 癌 / 細胞性免疫 / eTreg / 抗がん薬治療 / 免疫治療学 / 抗CCR4抗体 / Tax / HTLV-1 / NOGマウス / ATL / CTL / Treg / モガムリズマブ / 細胞傷害性T細胞(CTL) / CT 抗原 / 制御性T細胞(Treg) / CCR4 / 低フコシル化抗体 Less

Development of novel Treg targeting cancer immunotherapy based on Treg immune suppressive mechanism in cancerPrincipal Investigator
- Principal Investigator
  
  鈴木進
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Aichi Medical University
制御性Ｔ細胞の機能に着目した進行腎癌一次治療の選択に有用なバイオマーカーの探索
- Principal Investigator
  
  金尾健人
- Project Period (FY)
  2022 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Saitama Medical University
Development of novel cancer immunotheray by combining regulatory T-cell elimination and TGF-b inhibitorsPrincipal Investigator
- Principal Investigator
  
  鈴木進
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Aichi Medical University
頸部リンパ節における腫瘍免疫環境の解明-免疫学的頸部郭清術の確立を目指して
- Principal Investigator
  
  小川徹也
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Aichi Medical University
Development of the novel target therapy for leukemia with FLT3 mutations, using genetically modified FLT3-mutation knock-in human myeloid leukemia cells
- Principal Investigator
  
  Hanamura Ichiro
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Aichi Medical University
Basic research for development of novel cancer immunotherapy based on improvement of the cancer immunosuppressive microenvironmentPrincipal Investigator
- Principal Investigator
  
  Suzuki Susumu
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Aichi Medical University
Development of a New Immunochemotherapy for Head and Neck Cancer - Significance of Combination of CTL and Anticancer Drugs
- Principal Investigator
  
  Ogawa Tetsuya
- Project Period (FY)
  2017 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Otorhinolaryngology
- Research Institution
  Aichi Medical University
Development of Intracellular Molecularly Targeted Therapy Targeting E7 Protein of HPV that Initiates Cervical Cancer
- Principal Investigator
  
  Yoshikawa Kazuhiro
- Project Period (FY)
  2017 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Aichi Medical University
Development of novel cancer immunotherapy based on comprehensive control of effector regulatory T-cellsPrincipal Investigator
- Principal Investigator
  
  Suzuki Susumu
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Aichi Medical University
Development of comprehensive immunotherapy by defuccosylated antibody
- Principal Investigator
  
  UEDA Ryuzo
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Tumor immunology
- Research Institution
  Aichi Medical University
  Nagoya City University

All 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 Other

All Journal Article Presentation Book

[Book] 最新医学2016
- Author(s)
  鈴木進、中山睿一、黒瀬浩史、上田龍三　モガムリズマブの新しい展開
- Total Pages
  7
- Publisher
  最新医学社
- Data Source
  KAKENHI-PROJECT-26430173
[Book] 臨床血液2015
- Author(s)
  正木彩子, 石田高司、前田康弘、鈴木進、上田龍三、飯田真介
- Total Pages
  10
- Publisher
  臨床血液学会
- Data Source
  KAKENHI-PROJECT-26430173
[Book] Progress in clinical use of CCR4 antibody for regulatory T cell suppression. Inflammation and Immunity in Cancer.2015
- Author(s)
  Suzuki S, Ishida T, Yoshikawa K, Ueda R.
- Total Pages
  11
- Publisher
  Springer
- Data Source
  KAKENHI-PROJECT-26430173
[Book] Clinical application of anti-CCR4 monoclonal antibody. Recent advances in cancer immunotherapy2014
- Author(s)
  Ueda R, Suzuki S, Yoshikawa K, Ishida T.
- Total Pages
  6
- Publisher
  Princess Takamatsu Cancer Research Fund
- Data Source
  KAKENHI-PROJECT-26430173
[Book] Progress in clinical use of CCR4 antibody for Treg cell suppression.
- Author(s)
  Suzuki S, Ishida T, Yoshikawa K and Ueda R.
- Publisher
  Inflammation and Immunity in Cancer
- Data Source
  KAKENHI-PROJECT-22300333
[Journal Article] Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens2023
- Author(s)
  Yamanaka S, Suzuki S, Ito H, Sivasundaram K, Hanamura I, Okubo I, Yoshikawa K, Ono S, Takahara T, Satou A, Tsuzuki T, Ueda R, Ogawa T, Fujimoto Y.
- Journal Title
  
  International journal of molecular sciences
  
  Volume: 24 Issue: 2 Pages: 1722-1722
- DOI
  10.3390/ijms24021722
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07203, KAKENHI-PROJECT-21K08427, KAKENHI-PROJECT-20K16205, KAKENHI-PROJECT-17K11301, KAKENHI-PROJECT-19K09292
[Journal Article] In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among Patients2022
- Author(s)
  Kondo Y, Suzuki S, Ono S, Goto M, Miyabe S, Ogawa T, Tsuchida H, Ito H, Takahara T, Satou A, Tsuzuki T, Yoshikawa K, Ueda R, Nagao T.
- Journal Title
  
  International journal of molecular sciences
  
  Volume: 23 Issue: 8 Pages: 4077-4077
- DOI
  10.3390/ijms23084077
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07203
[Journal Article] An In Vivo Study of Local Administration of Low-dose Anti-PD-1 Antibody Using an Oral Cancer Cell Line.2022
- Author(s)
  Sakuma K, Kii T, Takahashi H, Suzuki S, Yoshikawa K, Ogawa T, Tanaka A.
- Journal Title
  
  Ainticancer Research
  
  Volume: 42 Issue: 9 Pages: 4293-4303
- DOI
  10.21873/anticanres.15929
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07203, KAKENHI-PROJECT-17K11301, KAKENHI-PROJECT-19K19214
[Journal Article] Trametinib improves Treg selectivity of anti-CCR4 antibody by regulating CCR4 expression in CTLs in oral squamous cell carcinoma2022
- Author(s)
  Ono S, Suzuki S, Kondo Y, Okubo I, Goto M, Ogawa T, Kato H, Ito H, Takahara T, Satou A, Tsuzuki T, Yoshikawa K, Nagao T, Ueda R.
- Journal Title
  
  Scientific Reports
  
  Volume: 12 Issue: 1 Pages: 21678-21678
- DOI
  10.1038/s41598-022-22773-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07203, KAKENHI-PROJECT-17K11301
[Journal Article] Improving function of cytotoxic T‐lymphocytes by transforming growth factor‐β inhibitor in oral squamous cell carcinoma2021
- Author(s)
  Kondo Yutaro、Suzuki Susumu、Takahara Taishi、Ono Shoya、Goto Mitsuo、Miyabe Satoru、Sugita Yoshihiko、Ogawa Tetsuya、Ito Hideaki、Satou Akira、Tsuzuki Toyonori、Yoshikawa Kazuhiro、Ueda Ryuzo、Nagao Toru
- Journal Title
  
  Cancer Science
  
  Volume: 112 Issue: 10 Pages: 4037-4049
- DOI
  10.1111/cas.15081
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K10081, KAKENHI-PROJECT-21K07203
[Journal Article] Combining T‐cell‐based immunotherapy with venetoclax elicits synergistic cytotoxicity to B‐cell lines in vitro2020
- Author(s)
  Murakami Satsuki、Suzuki Susumu、Hanamura Ichiro、Yoshikawa Kazuhiro、Ueda Ryuzo、Seto Masao、Takami Akiyoshi
- Journal Title
  
  Hematological Oncology
  
  Volume: 38 Issue: 5 Pages: 705-714
- DOI
  10.1002/hon.2794
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08343, KAKENHI-PROJECT-18K07277
[Journal Article] Pathological and Virological Studies of p16-Positive Oropharyngeal Carcinoma with a Good Response to Neoadjuvant Chemotherapy2020
- Author(s)
  Inukai Daisuke、Kan Taichi、Yamanaka Shunpei、Okamoto Hiroki、Fujimoto Yasushi、Ito Takanori、Taniguchi Natsuki、Yamamoto Yuuki、Tsuzuki Toyonori、Takami Akiyoshi、Ogawa Tetsuya
- Journal Title
  
  Microorganisms
  
  Volume: 8 Issue: 10 Pages: 1497-1497
- DOI
  10.3390/microorganisms8101497
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K11412, KAKENHI-PROJECT-18K08343
[Journal Article] Immune-checkpoint molecules on regulatory T-cells as potential therapeutic target in head and neck squamous cell cancers.2020
- Author(s)
  Suzuki S, Ogawa T, Sano R, Takahara T, Inukai D, Satou A, Tsuchida H, Yoshikawa K, Ueda R, Tsuzuki T
- Journal Title
  
  Cancer Sci.
  
  Volume: in press Issue: 6 Pages: 1943-1957
- DOI
  10.1111/cas.14422
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07277, KAKENHI-PROJECT-17K11412, KAKENHI-PROJECT-20K18327
[Journal Article] Clinical significance of tryptophan catabolism in follicular lymphoma2020
- Author(s)
  Masaki Ayako、Ishida Takashi、Maeda Yasuhiro、Ito Asahi、Suzuki Susumu、Narita Tomoko、Kinoshita Shiori、Yoshida Takashi、Ri Masaki、Kusumoto Shigeru、Komatsu Hirokazu、Inagaki Hiroshi、Ueda Ryuzo、Choi Ilseung、Suehiro Youko、Iida Shinsuke
- Journal Title
  
  Hematological Oncology
  
  Volume: 38 Issue: 5 Pages: 742-753
- DOI
  10.1002/hon.2804
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K16095, KAKENHI-PROJECT-18H02633, KAKENHI-PROJECT-18K07277
[Journal Article] Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphoma2020
- Author(s)
  Saito Masato、Ishii Toshihiko、Urakawa Itaru、Matsumoto Asuka、Masaki Ayako、Ito Asahi、Kusumoto Shigeru、Suzuki Susumu、Takahashi Takeshi、Morita Akimichi、Inagaki Hiroshi、Iida Shinsuke、Ishida Takashi
- Journal Title
  
  Blood Advances
  
  Volume: 4 Issue: 10 Pages: 2180-2191
- DOI
  10.1182/bloodadvances.2020001641
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K16095, KAKENHI-PROJECT-18K07277
[Journal Article] Increased infiltration of CCR4-positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis.2019
- Author(s)
  Watanabe M, Kanao K, Suzuki S, Muramatsu H, Morinaga S, Kajikawa K, Kobayashi I, Nishikawa G, Kato Y, Zennami K, Nakamura K, Tsuzuki T, Yoshikawa K, Ueda R, Sumitomo M.
- Journal Title
  
  Prostate
  
  Volume: 79(14) Issue: 14 Pages: 1658-1665
- DOI
  10.1002/pros.23890
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11163, KAKENHI-PROJECT-18K07210, KAKENHI-PROJECT-18K07277, KAKENHI-PROJECT-18K16715
[Journal Article] Mogamulizumab treatment elicits autoantibodies attacking the skin in patients with adult T cell leukemia-lymphoma2019
- Author(s)
  Suzuki Yui、Saito Masato、Ishii Toshihiko、Urakawa Itaru、Matsumoto Asuka、Masaki Ayako、Ito Asahi、Kusumoto Shigeru、Suzuki Susumu、Hiura Masanori、Takahashi Takeshi、Morita Akimichi、Inagaki Hiroshi、Iida Shinsuke、Ishida Takashi
- Journal Title
  
  Clinical Cancer Research
  
  Volume: 印刷中 Issue: 14 Pages: 4388-4399
- DOI
  10.1158/1078-0432.ccr-18-2575
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K16095, KAKENHI-PROJECT-16H04713, KAKENHI-PROJECT-18K07277, KAKENHI-PROJECT-18H02633
[Journal Article] CCR4 expression in tumor-infiltrating regulatory T cells in patients with squamous cell carcinoma of the lung: A prognostic factor for relapse and survival2019
- Author(s)
  Kubo A, Asai N, Suzuki S, Murotani K, Numanami H, Yoshikawa K, Ueda R, Yamaguchi E
- Journal Title
  
  Cancer Invest
  
  Volume: 37 Issue: 3 Pages: 163-73
- DOI
  10.1080/07357907.2019.1582848
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K07128, KAKENHI-PROJECT-18K07277
[Journal Article] Immunomodulatory and Metabolic Changes after Gnetin-C Supplementation in Humans.2019
- Author(s)
  Nakagami Y, Suzuki S, Espinoza JL, Vu Quang L, Enomoto M, Takasugi S, Nakamura A, Nakayama T, Tani H, Hanamura I, Takami A
- Journal Title
  
  Nutrients
  
  Volume: 11 Issue: 6 Pages: 1403-1403
- DOI
  10.3390/nu11061403
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07277, KAKENHI-PROJECT-18K08343, KAKENHI-PROJECT-17K09944
[Journal Article] Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients.2018
- Author(s)
  Kato R, Yamasaki M, Urakawa S, Nishida K, Makino T, Morimoto-Okazawa A, Kawashima A, Iwahori K, Suzuki S, Ueda R, Mori M, Satoh T, Doki Y, Wada H.
- Journal Title
  
  Cancer Immunol Immunother.
  
  Volume: 67 Issue: 11 Pages: 1673-1683
- DOI
  10.1007/s00262-018-2225-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07277
[Journal Article] Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals.2018
- Author(s)
  Masaki A, Ishida T, Suzuki S, Ito A, Narita T, Kinoshita S, Ri M, Kusumoto S, Komatsu H, Inagaki H, Ueda R, Iida S.
- Journal Title
  
  Cancer Sci
  
  Volume: 109 Issue: 8 Pages: 2383-2390
- DOI
  10.1111/cas.13654
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07277, KAKENHI-PROJECT-18K16095, KAKENHI-PROJECT-16H04713, KAKENHI-PROJECT-18H02633
[Journal Article] Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study2017
- Author(s)
  Nishio-Nagai Mayako、Suzuki Susumu、Yoshikawa Kazuhiro、Ueda Ryuzo、Kazaoka Yoshiaki
- Journal Title
  
  International Journal of Oncology
  
  Volume: 51 Issue: 5 Pages: 1471-1481
- DOI
  10.3892/ijo.2017.4142
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K11301
[Journal Article] モガムリズマブの新しい展開2016
- Author(s)
  鈴木進、中山睿一、黒瀬浩史、上田龍三
- Journal Title
  
  最新医学
  
  Volume: 71 Pages: 126-132
- NAID
  40020708354
- Data Source
  KAKENHI-PROJECT-26430173
[Journal Article] がん細胞に対する抗体の現状と展望2016
- Author(s)
  鈴木進、吉川和宏、上田龍三
- Journal Title
  
  実験医学
  
  Volume: 34 Pages: 122-131
- Data Source
  KAKENHI-PROJECT-26430173
[Journal Article] Current status of immunotherapy.2016
- Author(s)
  Suzuki S, Ishida T, Yoshikawa K and Ueda R.
- Journal Title
  
  Jpn J Clin Oncol
  
  Volume: 46 Issue: 3 Pages: 191-203
- DOI
  10.1093/jjco/hyv201
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26430173, KAKENHI-PROJECT-24592415
[Journal Article] Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients.2015
- Author(s)
  2.Kurose K, Ohue Y, Wada H, Iida S, Ishida T, Kojima T, Doi T, Suzuki S, Isobe M, Funakoshi T, Kakimi K, Nishikawa H, Udono H, Oka M, Ueda R, Nakayama E.
- Journal Title
  
  Clin Cancer Res.
  
  Volume: 21 Issue: 19 Pages: 4327-36
- DOI
  10.1158/1078-0432.ccr-15-0357
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26430173, KAKENHI-PROJECT-15K14403, KAKENHI-PROJECT-25430161, KAKENHI-PROJECT-26670237, KAKENHI-PROJECT-26670581, KAKENHI-PROJECT-26830117, KAKENHI-PROJECT-25290058, KAKENHI-PROJECT-26290054, KAKENHI-PROJECT-26290056
[Journal Article] Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma.2015
- Author(s)
  Masaki A, Ishida T, Maeda Y, Suzuki S, Ito A, Takino H, Ogura H, Totani H, Yoshida T, Kinoshita S, Narita T, Ri M, Kusumoto S, Inagaki A, Komatsu H, Niimi A, Ueda R, Utsunomiya A, Inagaki H, Iida S.
- Journal Title
  
  Clin Cancer Res.
  
  Volume: -
- NAID
  130005130183
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26430173
[Journal Article] Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma2015
- Author(s)
  Masaki, A., Ishida, T., Maeda, Y., Suzuki, S., Ito, A., Takino, H., Ogura, H., Totani, H., Yoshida, T., Kinoshita, S., Narita, T., Ri, M., Kusumoto, S., Inagaki, A., Komatsu, H., Niimi, A., Ueda, R., Utsunomiya, A., Inagaki, H. & Iida, S.
- Journal Title
  
  Clinical cancer research : an official journal of the American Association for Cancer Research
  
  Volume: 21 (12) Issue: 12 Pages: 2830-2839
- DOI
  10.1158/1078-0432.ccr-14-2275
- NAID
  130005130183
- Description
  印刷中
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-221S0001, KAKENHI-PROJECT-15K08351, KAKENHI-PROJECT-26430173, KAKENHI-PROJECT-25290058
[Journal Article] モガムリズマブ2014
- Author(s)
  鈴木進, 石田高司, 吉川和宏, 上田龍三
- Journal Title
  
  The Frontiers in Life Sciences. 生命科学から創薬へのイノベーション
  
  Volume: 1 Pages: 183-195
- Data Source
  KAKENHI-PROJECT-26430173
[Journal Article] Autologous Tax-Specific CTL Therapy in a Primary Adult T Cell Leukemia/Lymphoma Cell-Bearing NOD/Shi-scid2013
- Author(s)
  Ishida T, Suzuki S, Ueda R.
- Journal Title
  
  IL-2Rγnull Mouse Model. J Immunol
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22300333
[Journal Article] Angioimmunoblastic T-cell lymphoma mice model2013
- Author(s)
  Ishida T, Suzuki S, Ueda R
- Journal Title
  
  Leuk Res
  
  Volume: 37 Pages: 21-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22300333
[Journal Article] Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma2012
- Author(s)
  Suzuki S, Ishida T, Ueda R.
- Journal Title
  
  Cancer Sci
  
  Volume: 103 Pages: 1764-73
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22300333
[Journal Article] Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma.2012
- Author(s)
  Suzuki S
- Journal Title
  
  Cancer Sci.
  
  Volume: 103 Issue: 10 Pages: 1764-73
- DOI
  10.1111/j.1349-7006.2012.02371.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22300333, KAKENHI-PROJECT-22689029, KAKENHI-PROJECT-23300354, KAKENHI-PROJECT-24590422, KAKENHI-PROJECT-221S0001
[Presentation] Establishment passive culture cells derived from mucoepidermoid carcinoma2022
- Author(s)
  Shunpei Yamanaka, Susumu Suzuki, Hideaki Ito, Shoya Ono, Yutaro Kondo, Daisuke Inukai, Hiroki Okamoto, Taishi Takahara, Toyonori Tsuzuki, Kazuhiro Yoshikawa, Ryuzo Ueda, Tetsuya Ogawa
- Organizer
  日本癌学会
- Data Source
  KAKENHI-PROJECT-17K11301
[Presentation] Transforming growth factor-beta inhibitor is a candidate drug for immunotherapy of oral squamous cell carcinoma2022
- Author(s)
  Yutaro Kondo, Taishi Takahara, Shoya Ono, Mitsuo Goto, Tetsuya Ogawa, Hideaki Ito, Akira Sato, Toyonori Tsuzuki, Kazuhiro Yoshikawa, Ryuzo Ueda, Susumu Suzuki
- Organizer
  日本癌学会
- Data Source
  KAKENHI-PROJECT-17K11301
[Presentation] Trametinib improves Treg selectivity of anti-CCR4 mAb by regulating CCR4 expression in CTLs induced via TCR/TGF-β signaling2022
- Author(s)
  Ono S, Suzuki S, Kondo Y, Okubo I, Goto M, Ogawa T, Kato H, Ito H, Takahara T, Satou A, Tsuzuki T, Yoshikawa K, Nagao T, Ueda R.
- Organizer
  日本癌学会
- Data Source
  KAKENHI-PROJECT-21K07203
[Presentation] Transforming growth factor-β inhibitor is a candidate drug for immunotherapy of oral squamous cell carcinoma2021
- Author(s)
  Kondo Y, Suzuki S, Takahara T, Ono S, Goto M, Miyabe S, Sugita Y, Ogawa T, Ito H, Satou A, Tsuzuki T, Yoshikawa K, Ueda R, Nagao T.
- Organizer
  第80回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21K07203
[Presentation] CD52 is a novel target for the treatment of FLT3-ITD mutated leukemia2021
- Author(s)
  花村一朗, カルナンシバンスンダラン, 太田明伸, 鈴木進, 高杉壮一, 中村文乃, 高橋美裕希, 村上五月, 上田龍三, 細川好孝, 高見昭良
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K08825
[Presentation] Comparison of eTreg frequency status between metastatic and non-metastatic lymphnodes in head and neck cancer2020
- Author(s)
  Ogawa T, Suzuki S, Sano R, Inukai D, Okamoto H, Takahara T, Yoshikawa K, Ueda R, Tsuzuki T
- Organizer
  第79回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07277
[Presentation] Synergistic Effect of Venetoclax for Antibody Dependent Cell Cytotoxicity By Daratumumab2020
- Author(s)
  Ayano Nakamura, Susumu Suzuki, Masao Seto, Souichi Takasugi, Jo Kanasugi, Ichiro Hanamura, Ryuzo Ueda, Akiyoshi Takami
- Organizer
  62nd ASH annual meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07277
[Presentation] PD-L1 expression mechanisms are heterogeneous in oral cancer2020
- Author(s)
  Kondo Y, Suzuki S, Goto M, Ono Syoya, Ogawa T, Yoshikawa K, Tuzuki T, Ueda R
- Organizer
  第79回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07277
[Presentation] Analysis of frequency and TCR repertoires of regulatory T-cell (Treg) of drain lymph node in head and neck cancer2020
- Author(s)
  Suzuki S, Ogawa T, Sano R, Inukai D, Okamoto H, Takahara T, Sito M, Ishii T, Yoshikawa K, Ueda R, Tsuzuki T
- Organizer
  第79回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07277
[Presentation] Characterization of tumor immune-microenvironmen (TIME) in papillary thyroid cancer (PTC).2019
- Author(s)
  Okamoto H, Suzuki S, Ogawa T, Inukai D, Sano R, Takahara T, Satou A, Yoshikawa K, Tsuzuki T, Ueda R
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07277
[Presentation] Development New Strategy for Head and Neck Immunotherapy from the Perspective of Translational and Reverse Translational Research2019
- Author(s)
  Ogawa T, Okamoto H, Inukai D, Sano R, Yamanaka S, Ueda H, Takahara T, Tsuzuki T, Yoshikawa K, Suzuki S, Ueda R
- Organizer
  第57回日本癌治療学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07277
[Presentation] New strategy of immunotherapy for head and neck squamous cell cancers (HNSCCs) combined with IC and Treg inhibitors.2019
- Author(s)
  Suzuki S, Ogawa T, Inukai D, Okamoto H, Sano R, Takahara T, Satou A, Yoshikawa K, Tsuzuki T, Ueda R
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07277
[Presentation] Multicolor analysis of characterization of immuno-suppressive microenvironment in head & neck cancer.2019
- Author(s)
  Sano R, Suzuki S, Ogawa T, Inukai D , Okamoto H, Takahara T, Satou A, Yoshikawa K, Tsuzuki T, Ueda R
- Organizer
  6th Asian society of head and neck oncology.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11412
[Presentation] Characterization of immune-suppressive microenvironment in head & neck cancer.2018
- Author(s)
  1.Sano R, Suzuki S, Ogawa T, Inukai D, Okamoto H, Takahara T, Sato A, Yoshikawa K, Tsuzuki T, Ueda R.
- Organizer
  第77回日本癌学会総会
- Data Source
  KAKENHI-PROJECT-18K07277
[Presentation] Interim immunostaining results from phase I study of pre-operative combination therapy with mogamulizumab and nivolumab.2018
- Author(s)
  2.Suzuki S, Tsuzuki T, Ishida T, Kojima T, Kakimi K, Iida S, Oka M, Doki Y, Nishikawa H, Ueda R, and Wada H.
- Organizer
  第77回日本癌学会総会
- Data Source
  KAKENHI-PROJECT-18K07277
[Presentation] Characterization of immune-suppressive microenvironment in head & neck cancer.2018
- Author(s)
  Sano R, Suzuki S, Ogawa T, Inukai D , Okamoto H, Takahara T, Satou A, Yoshikawa K, Tsuzuki T, Ueda R
- Organizer
  第77回日本癌学会学術総会.
- Data Source
  KAKENHI-PROJECT-17K11412
[Presentation] 頭頸部がん手術検体を用いたeffector Tregの腫瘍内発現の解析2017
- Author(s)
  鈴木進, 西村邦宏, 小川徹也, 都築豊徳, 吉川和宏, 上田龍三
- Organizer
  日本癌学会
- Data Source
  KAKENHI-PROJECT-17K11301
[Presentation] CDK9 as target for treatment in EBV associated T- and NK-cell lymphoproliferative diseases.2016
- Author(s)
  Kinoshita S, Ishida T, Narita T, Itou A, Masaki A, Suzuki S, Ri M, Kusumoto S, Komatsu H, Kuroda T, Inagaki H, Abe Y, Ueda R and Iida S.
- Organizer
  第75回日本癌学会総会
- Place of Presentation
  横浜
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] Prognostic significance of tryptophan catabolism in newly diagnosed Hodgkin Lymphoma.2016
- Author(s)
  Masaki A, Ishida T, Narita T, Itou A, Suzuki S, Kusumoto S, Komatsu H, Ilseung C, Suehiro Y, Abe Y, Inagaki H, Ueda R and Iida S.
- Organizer
  第78回日本血液学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2016-10-13
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] Prognostic significance of tryptophan catabolism in newly diagnosed Hodgkin Lymphoma.2016
- Author(s)
  Masaki A, Ishida T, Narita T, Itou A, Suzuki S, Kusumoto S, Komatsu H, Ilseung C, Suehiro Y, Abe Y, Inagaki H, Ueda R and Iida S.
- Organizer
  第75回日本癌学会総会
- Place of Presentation
  横浜
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] Indoleamine 2,3-dioxygenase 1 as a novel molecular target in adult T-cell leukemia/lymphoma.2016
- Author(s)
  Ishida T, Ito A,Masaki A, Saito M, Urakawa I, Ishii T, Suzuki S, Kusumoto S, Komatsu H, Inagaki H, Iida S, Takahashi T and Ueda R.
- Organizer
  第75回日本癌学会総会
- Place of Presentation
  横浜
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] Indoleamine 2,3-dioxygenase 1 as a novel molecular target in adult T-cell leukemia/lymphoma.2016
- Author(s)
  Ishida T, Ito A,Masaki A, Saito M, Urakawa I, Ishii T, Suzuki S, Kusumoto S, Komatsu H, Inagaki H, Iida S, Takahashi T and Ueda R.
- Organizer
  第78回日本血液学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2016-10-13
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] C-C chemokine receptor 4 positive regulatory T cells increased in biopsy specimens of poorly prognostic prostate cancer.2016
- Author(s)
  Watanabe M, Kanao K, Suzuki S, Nakamura K, Yoshikawa K, Ueda R, and Sumitomo M. C-C chemokine receptor 4 positive regulatory T cells increased in biopsy specimens of poorly prognostic prostate cancer.
- Organizer
  第75回日本癌学会総会
- Place of Presentation
  横浜
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] 5-FU (fluorouracil) sensitizes oral squamous cell carcinoma (OSCC) to cytotoxic T-lymphocyte (CTL).2016
- Author(s)
  Suzuki S, Nishio M, Ohmura Y, Yoshikawa K, Kazaoka Y and Ueda R.
- Organizer
  第75回日本癌学会総会
- Place of Presentation
  横浜
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] CDK9 as target for treatment in EBV associated T- and NK-cell lymphoproliferative diseases.2016
- Author(s)
  Kinoshita S, Ishida T, Narita T, Itou A, Masaki A, Suzuki S, Ri M, Kusumoto S, Komatsu H, Kuroda T, Inagaki H, Abe Y, Ueda R and Iida S.
- Organizer
  第78回日本血液学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2016-10-13
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] Phase Ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients2015
- Author(s)
  Kurose K, Ohue Y, Wada H, Iida S, Ishida T, Suzuki S, Kakimi K, Nishikawa H, Ueda R, Oka M, Nakayama E.
- Organizer
  第74回日本癌学会総会
- Place of Presentation
  名古屋
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] Phase Ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients.2015
- Author(s)
  Kurose K, Ohue Y, Wada H, Iida S, Ishida T, Kojima T, Doi T, Suzuki S, Isobe M, Funakoshi T, Kakimi K, Nishikawa H, Udono H, Oka M, Ueda R and Nakayama E.
- Organizer
  第19回日本がん免疫学会総会
- Place of Presentation
  東京
- Year and Date
  2015-07-09
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] Potential treatment of adult T-cell leukemia/lymphoma by a novel P-TEFb/CDK9 inhibitor BAY11435722015
- Author(s)
  Narita T, Ishida T, Ito A, Masaki A, Suzuki S, Takino H, Ogura H, Yoshida T, Ri M, Kusumoto S, Komatsu H, Imada K, Takaori KA, Inagaki H, Arne S, Stuart I, Ueda R, and Iida S.
- Organizer
  第77回日本血液学会学術集会
- Place of Presentation
  金沢
- Year and Date
  2015-10-16
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] Indoleamine 2,3-dioxygenase 1 as a novel molecular target in adult T-cell leukemia/lymphoma.2015
- Author(s)
  Masaki A, Ishida T, Meda Y, Suzuki S, Ito A, Ogura H, Narita T, Totani H, Kinoshita S, Yoshida T, Ri M, Kusumoto S, Komatsu H, Ueda R, Inagaki H and Iida S.
- Organizer
  第77回日本血液学会学術集会
- Place of Presentation
  金沢
- Year and Date
  2015-10-16
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] Indoleamine 2,3-dioxygenase 1 as a novel molecular target in adult T-cell leukemia/lymphoma.2015
- Author(s)
  Masaki A, Ishida T, Suzuki S, Ito A, Narita T, Ri M, Kusumoto S, Komatsu H, Ueda R, Inagaki H, Iida S.
- Organizer
  第74回日本癌学会総会
- Place of Presentation
  名古屋
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] Immunotherapy for solid tumors based on regulation of regulatory T lymphocyte.2015
- Author(s)
  Suzuki S, Ishida T, Kurose K, Ohue Y, Nishikawa H, Iida S, Wada H, Oka M, Nakayama E and Ueda R.
- Organizer
  第74回日本癌学会総会
- Place of Presentation
  名古屋
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] 成人T細胞性白血病/リンパ腫におけるindoleamine 2,3-dioxygenaseの臨床的意義.2014
- Author(s)
  正木彩子、石田高司、前田康博、稲垣淳、鈴木進、伊藤旭、成田朋子、榊原健夫、滝野寿、李政樹、楠本茂、小松弘和、上田龍三、稲垣宏、宇都宮與、飯田真介
- Organizer
  第54回日本リンパ網内系学会総会
- Place of Presentation
  山形
- Year and Date
  2014-06-21
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] Chemo-immunotherapy with CTL and 5-fluorouracil (5FU) for head and neck squamous cell carcinoma (HNSCC).2014
- Author(s)
  Nishio-Nagai M, Suzuki S, Hayashi T, Ohmura Y, Yamada Y, Yoshikawa K, Ueda R and Kazaoka Y.
- Organizer
  22nd Annual International Cancer Immunotherapy Symposium.
- Place of Presentation
  ニューヨーク
- Year and Date
  2014-10-05
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] 口頸部扁平上皮癌（HNSCC）における5-フルオロウラシル(５－FU）併用免疫療法.2014
- Author(s)
  西尾麻矢子、鈴木　進、大村元伸、山田陽一、上田龍三、吉川和宏、風岡宜暁
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2014-09-27
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] CCR4を標的抗原とする、新規がん免疫療法.2014
- Author(s)
  石田高司、鈴木　進、上田龍三
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2014-09-26
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] 制御性T細胞解析方法の標準化に向けた多施設共同研究2014
- Author(s)
  長瀬博次、和田　尚、西川博嘉、鈴木　進、平家勇司、小嶋隆嗣、垣見和宏、舩越　建、飯田真介、石田高司、佐藤永一、鵜殿平一郎、岡三喜男、中山睿一、土岐祐一郎、上田龍三
- Organizer
  第18回日本がん免疫学会総会
- Place of Presentation
  松山
- Year and Date
  2014-07-31
- Data Source
  KAKENHI-PROJECT-26430173
[Presentation] Development of CTL preparation kit for adoptive T cell immunotherapy.2013
- Author(s)
  Suzuki S, Ueda R.(他3名)
- Organizer
  20th Annual Cancer Research Institute International Symposium. Cancer Immunotherapy 2012
- Place of Presentation
  New York
- Data Source
  KAKENHI-PROJECT-22300333
[Presentation] Development of CTL preparation kit for adoptive T cell immunotherapy.2012
- Author(s)
  Suzuki S
- Organizer
  20th Annual Cancer Research Institute International Symposium. Cancer Immunotherapy
- Place of Presentation
  New York
- Data Source
  KAKENHI-PROJECT-22300333
[Presentation] Potent Tax-specific CTL response to primary autologous ATL cells2011
- Author(s)
  鈴木進
- Organizer
  第73回日本血液学会
- Place of Presentation
  名古屋国際会議場(愛知県)
- Year and Date
  2011-10-16
- Data Source
  KAKENHI-PROJECT-22300333
[Presentation] Bevacizumab-induced potent antitumor effect in a microenvironment-dependentmouse lymphoma model.2011
- Author(s)
  石田高司、鈴木進、上田龍三(他8名)
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-22300333
[Presentation] Enhancement of HTLV-1 tax protein expression and the response of tax specific CTL by HDAC inhibitor.2011
- Author(s)
  SuzukiS,IshidaT,UedaR.(他11名)
- Organizer
  第73回日本血液学会学術集会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-22300333
[Presentation] Enhancement of HTLV-1 tax protein expression and the response of tax specific CTL by HDAC inhibitor.
- Author(s)
  Suzuki S, Ishida T, Ueda R. (他 9 名)
- Organizer
  The 73th Annual Meeting of the Japanese Society of Hematology
- Place of Presentation
  Nagoya
- Data Source
  KAKENHI-PROJECT-22300333
[Presentation] Potent antitumor effects of bevacizumab in a microenviroment-dependent human ATL
- Author(s)
  Ishida T, Suzuki S, Ueda R,(他14名)
- Organizer
  The 74th Annual Meeting of the Japanese Society of Hematology
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-22300333
[Presentation] Autologous Tax-specific CTL therapy in a primary ATL cell-bearing NOG mouse model.
- Author(s)
  Ishida T, Suzuki S, Ueda R.(他9名)
- Organizer
  The 74th Annual Meeting of the Japanese Society of Hematology
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-22300333

1. Ogawa Tetsuya (40334940)

# of Collaborated Projects: 5 results

# of Collaborated Products: 17 results
2. Yoshikawa Kazuhiro (60109759)

# of Collaborated Projects: 4 results

# of Collaborated Products: 15 results
3. 都築豊徳 (70627645)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
4. UEDA Ryuzo (20142169)

# of Collaborated Projects: 2 results

# of Collaborated Products: 39 results
5. Hanamura Ichiro (70440740)

# of Collaborated Projects: 2 results

# of Collaborated Products: 3 results
6. シバスンダランカルナン (30557096)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
7. ISHIDA Takashi (80405183)

# of Collaborated Projects: 1 results

# of Collaborated Products: 10 results
8. 伊藤旭 (00571762)

# of Collaborated Projects: 1 results

# of Collaborated Products: 12 results
9. 佐野塁 (50813846)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
10. 太田明伸 (30438048)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
11. 藪下廣光 (00140046)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 土本純 (70632868)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 金尾健人 (20327620)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. MIYABE Satoru

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
15. NAGAO Toru

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
16. SUMITOMO Makoto

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
17. ITO Hidemi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
18. SUZUKI Hiromu

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
19. KUBO Akihito

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
20. 高見昭良

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
21. 正木彩子

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
22. 鈴木登

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
23. 鈴木貞夫

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
24. 鈴木操

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
25. 吉田稔

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

suzuki susumu 鈴木 進

Suzuki Susumu 鈴木 進

SUZUKI Susumu 鈴木 進

Research Projects

Research Products

Co-Researchers

Development of novel Treg targeting cancer immunotherapy based on Treg immune suppressive mechanism in cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

制御性Ｔ細胞の機能に着目した進行腎癌一次治療の選択に有用なバイオマーカーの 探索

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of novel cancer immunotheray by combining regulatory T-cell elimination and TGF-b inhibitorsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

頸部リンパ節における腫瘍免疫環境の解明-免疫学的頸部郭清術の確立を目指して

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of the novel target therapy for leukemia with FLT3 mutations, using genetically modified FLT3-mutation knock-in human myeloid leukemia cells

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Basic research for development of novel cancer immunotherapy based on improvement of the cancer immunosuppressive microenvironmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a New Immunochemotherapy for Head and Neck Cancer - Significance of Combination of CTL and Anticancer Drugs

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of Intracellular Molecularly Targeted Therapy Targeting E7 Protein of HPV that Initiates Cervical Cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of novel cancer immunotherapy based on comprehensive control of effector regulatory T-cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of comprehensive immunotherapy by defuccosylated antibody

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 最新医学2016

Author(s)

Total Pages

Publisher

Data Source

[Book] 臨床血液2015

Author(s)

Total Pages

Publisher

Data Source

[Book] Progress in clinical use of CCR4 antibody for regulatory T cell suppression. Inflammation and Immunity in Cancer.2015

Author(s)

Total Pages

Publisher

suzuki susumu 鈴木進

Suzuki Susumu 鈴木進

SUZUKI Susumu 鈴木進

制御性Ｔ細胞の機能に着目した進行腎癌一次治療の選択に有用なバイオマーカーの探索